ask="3.3000"
ask_size="300"
average_daily_volume="201526"
bid="N/A"
bid_size="N/A"
book_value="0.5630"
change="+0.3006"
change_from_200_day_moving_average="0.7108"
change_from_50_day_moving_average="0.4627"
change_from_52_week_high="-0.7294"
change_From_52_week_low="1.0806"
change_in_percent="+10.5845%"
close="3.1406"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.3080"
ebitda="-5.76M"
eps_estimate_current_year="-0.3400"
eps_estimate_next_quarter="-0.2100"
eps_estimate_next_year="-0.9100"
ex_dividend_date="N/A"
float_shares="16233000"
high="3.1500"
high_52_weeks="3.8700"
last_trade_date="2/1/2017"
last_trade_price="3.1406"
last_trade_size="300"
last_trade_time="3:59pm"
low="2.7500"
low_52_weeks="2.0600"
market_capitalization="58.69M"
moving_average_200_day="2.4298"
moving_average_50_day="2.6779"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="6.0000"
open="2.8600"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+29.2545%"
percent_change_from_50_day_moving_average="+17.2793%"
percent_change_from_52_week_high="-18.8475%"
percent_change_from_52_week_low="+52.4563%"
previous_close="2.8400"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.0444"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="1.2900"
stock_exchange="NCM"
symbol="BCLI"
volume="690968"
weeks_range_52="2.0600 - 3.8700"
